Tag : hospitalacquired

Latest News

FDA Accepts For Review Supplemental New Drug Application (sNDA) for RECARBRIO™ (imipenem, cilastatin, and relebactam) for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)

Newsemia
KENILWORTH, N.J.–(BUSINESS WIRE)—- $MRK #MRK–FDA Accepts For Review sNDA for RECARBRIO™ for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia Source link...
Latest News

Pivotal RESTORE-IMI 2 Phase 3 Study of Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) in Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Met Primary Endpoint

Newsemia
KENILWORTH, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Pivotal RESTORE-IMI 2 Phase 3 Study of Merck’s RECARBRIO™ in Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia Met Primary Endpoint Source link...
Pediatrics

Room Sharing in Hospitalized Children With Bronchiolitis and the Occurrence of Hospital-Acquired Infections: A Prospective Cohort Study

Newsemia
OBJECTIVES: To determine the prevalence and severity of hospital-acquired infections (HAIs) in children hospitalized for bronchiolitis when patients share a room, irrespective of the causative...
Cardiology

Admission characteristics predictive of in-hospital death from hospital-acquired sepsis: A comparison to community-acquired sepsis.

Newsemia
Related Articles Admission characteristics predictive of in-hospital death from hospital-acquired sepsis: A comparison to community-acquired sepsis. J Crit Care. 2019 Feb 19;51:145-148 Authors: Padro T,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy